Fredun Pharmaceuticals Ltd (FRED)

Currency in INR
1,693.90
-14.10(-0.83%)
Closed·
Trading near 52-week High
FREDUN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,655.301,735.00
52 wk Range
1,195.201,735.00
Key Statistics
Bid/Ask
1,682.00 / 1,693.90
Prev. Close
1,708
Open
1,713
Day's Range
1,655.3-1,735
52 wk Range
1,195.2-1,735
Volume
111.66K
Average Volume (3m)
102.74K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FREDUN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Fredun Pharmaceuticals Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Fredun Pharmaceuticals Ltd Earnings Call Summary for Q2/2027

  • Fredun Pharmaceuticals Q2 revenue surged 84.2% YoY to 2.68B rupees; net profit jumped 93.4% to 1.88B rupees with improved margins.
  • Company diversifying beyond traditional pharma into pet care, cosmetics, nutraceuticals and diagnostics; newer units growing 65-70% annually.
  • Management expects to exceed FY2027 target of 800 crore rupees, citing 7-8 month order book visibility and decade-long record of beating guidance.
  • Executives say 'actual growth' will materialize in next 18-24 months as ecosystem matures; multiple product launches planned including CAT business in 60-90 days.
  • Stock fell 0.81% despite strong results; risks include margin pressure from expansion, execution challenges across multiple verticals, and governance concerns.
Last Updated: 2026-11-16, 02:28 a/m
Read Full Transcript

Earnings

Latest Release
Nov 05, 2026
EPS / Forecast
10.92 / --
Revenue / Forecast
2.68B / --
EPS Revisions
Last 90 days

FREDUN Income Statement

Compare FREDUN to Peers and Sector

Metrics to compare
FREDUN
Peers
Sector
Relationship
P/E Ratio
58.7x32.3x−0.2x
PEG Ratio
1.470.290.00
Price/Book
8.5x3.5x2.6x
Price / LTM Sales
3.3x2.2x2.7x
Upside (Analyst Target)
-18.0%72.2%
Fair Value Upside
Unlock2.2%12.4%Unlock

Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America. The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, antibacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, anticoagulants, anticonvulsants, antidiarrhoeal, antidepressant, antifungal, antihistamines/antiallergic, antihypertensives, antiviral, bone modulating drugs, bronchodilators and anti-asthma drugs, calcium tablets, cardiovascular, diuretic, impotence drugs, laxative, and appetite stimulant with multivitamins. It also provides surgical products, such as IV fluids and cannulas, disposable syringes, infusion sets, surgical gloves and cottons, and personal healthcare products; APIs; direct compressible granules; pellets; animal healthcare products; aqua products; and niche products. Additionally, the company offers therapeutic products under the brand Hormone Range Products, a specialty therapeutics brand focused on longevity, hormone health, recovery science, and human performance solutions. Fredun Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Mumbai, India.

Employees
736
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
801.00K4.84%1.37B
Public Companies & Retail Investors
15.74M95.16%26.88B
Total
16.54M100.00%28.25B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Capri Global Capital Limited1.45%240,000409,920
Bank of India1.36%225,000384,300

People Also Watch

278.30
KROS
-2.50%
470.35
GNGL
-8.75%
4,374.50
CENT
-2.43%

FAQ

What Is the Fredun Pharmaceuticals (FREDUN) Stock Price Today?

The Fredun Pharmaceuticals stock price today is 1,693.90 INR.

What Stock Exchange Does Fredun Pharmaceuticals Trade On?

Fredun Pharmaceuticals is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Fredun Pharmaceuticals?

The stock symbol for Fredun Pharmaceuticals is "FREDUN."

What Is the Fredun Pharmaceuticals Market Cap?

As of today, Fredun Pharmaceuticals market cap is 28.00B INR.

What Is Fredun Pharmaceuticals's Earnings Per Share (TTM)?

The Fredun Pharmaceuticals EPS (TTM) is 30.05.

From a Technical Analysis Perspective, Is FREDUN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Fredun Pharmaceuticals Stock Split?

Fredun Pharmaceuticals has split 0 times.

How Many Employees Does Fredun Pharmaceuticals Have?

Fredun Pharmaceuticals has 736 employees.

What is the current trading status of Fredun Pharmaceuticals (FREDUN)?

As of Nov 20, 2026, Fredun Pharmaceuticals (FREDUN) is trading at a price of 1,693.90 INR, with a previous close of 1,708.00 INR. The stock has fluctuated within a day range of 1,655.30 INR to 1,735.00 INR, while its 52-week range spans from 1,195.20 INR to 1,735.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.